Breaking News
May 26, 2018 - Mice remain slim on burger diet
May 26, 2018 - BMC receives $13.5 million award to test methods for delivering childhood anxiety treatment
May 26, 2018 - ‘Right to Try Act’ will not benefit terminally-ill patients
May 26, 2018 - Study reveals novel statistical algorithm to identify potential disease genes
May 26, 2018 - Two genes play vital roles in malignant brain cancer
May 26, 2018 - Study explores link between groundwater lithium and diagnoses of bipolar disorder, dementia
May 26, 2018 - Researchers reveal stimulatory effects of myelin on young neural cells
May 26, 2018 - Small part of cellular protein that helps form long-term memories also drives neurodegeneration
May 26, 2018 - Four-legged friends can have heart issues, too
May 26, 2018 - Scientists create small, self-contained spaces inside mammalian cells
May 26, 2018 - Better Social Support Network Protects Black Men Against HIV
May 26, 2018 - National Heart, Lung, and Blood Institute (NHLBI)
May 26, 2018 - Burnout, depression can affect ophthalmology residents, study finds
May 26, 2018 - Latinos and African Americans more likely to experience serious depression than Whites
May 26, 2018 - Data from past epidemic could help improve response to future Ebola outbreaks
May 26, 2018 - Researchers provide insight into how the memory molecule limits brain plasticity
May 26, 2018 - OSU biologist describes ‘restoration ecology’ approach toward patient health
May 26, 2018 - New approach to study brown fat could aid in finding treatments for obesity
May 26, 2018 - Could More Fish in the Diet Boost Sex Lives and Fertility?
May 26, 2018 - NTU Singapore and SERI invent new scope to diagnose glaucoma
May 26, 2018 - Cancer cells co-opt pain-sensing ‘neural channel’ to increase tolerance against oxidative stress
May 26, 2018 - Study uncovers why pesticide exposure increases Parkinson’s disease risk in some people
May 26, 2018 - Study finds link between lead exposure and fertility rates
May 26, 2018 - Delivery of standardized diabetes care could help achieve equitable health outcomes for all patients
May 26, 2018 - FDA authorizes marketing of OsteoDetect software for detecting wrist fractures
May 26, 2018 - Children and adolescents growing up in extreme societal conditions more likely to resort to violence
May 26, 2018 - New study puts forth most comprehensive tree of life for malaria parasites
May 26, 2018 - Princeton Instruments and C-SOPS announce collaboration on innovative pharmaceutical technology
May 26, 2018 - New research shows why babies need to move in the womb
May 26, 2018 - UK steps forward to tackle global antimicrobial resistance
May 26, 2018 - CRISPR-Cas9-based strategy allows researchers to precisely alter hundreds of different genes
May 26, 2018 - Novoheart announces next generation of ‘Human heart-in-a-jar’ technology for advanced drug discovery
May 26, 2018 - UT Southwestern-led researchers find new way to determine prognosis of invasive kidney cancer
May 26, 2018 - Researchers develop film to prevent bacteria from growing on dental retainers and aligners
May 26, 2018 - Mobile health intervention for people with serious mental illness as effective as clinic-based treatment
May 26, 2018 - Vaginal estradiol tablets outperform moisturizers when treating vulvovaginal problems
May 26, 2018 - Researchers call for new genetic tests for congenital diseases
May 26, 2018 - KHN’s ‘What the Health?’ Campaign promises kept, plus ‘nerd reports’
May 26, 2018 - AARDA collaborates with Allegheny Health Network and new AHN Autoimmunity Institute
May 26, 2018 - Lung-on-a-chip technology could streamline drug-testing for pulmonary fibrosis
May 26, 2018 - Researchers work together to solve mystery of motor neuron death in ALS patients
May 26, 2018 - Study finds early antibiotic initiation for majority of premature infants
May 26, 2018 - New environmental monitoring project finds increased numbers of deer ticks in Southern Indiana
May 26, 2018 - Pediatricians Should Advocate for Life Support Training
May 26, 2018 - Cannabidiol significantly reduces seizures in patients with severe form of epilepsy
May 26, 2018 - Allergies can have serious, far-reaching consequences on adolescents
May 26, 2018 - Scientists develop lab-based system to study mechanisms of common liver disease
May 25, 2018 - New guidelines may help pathologists to more accurately classify and diagnose invasive melanoma
May 25, 2018 - Immune cells promote lung cancer metastases by forming clots in tumors, study finds
May 25, 2018 - Can Excess Weight in Toddlers Cause Brain Drain?
May 25, 2018 - Studying insight
May 25, 2018 - Researchers reveal potent new mechanism of action for treatment of IBD
May 25, 2018 - Study shows lack of follow-up care for patients with concussion
May 25, 2018 - Study establishes the importance of haploid cells
May 25, 2018 - Coveted BMJ award bestowed on The Clatterbridge Cancer Center
May 25, 2018 - AACN outlines evidence-based protocols and clinical strategies to manage alarms
May 25, 2018 - Origami inspires researchers to develop new solution for tissue regeneration
May 25, 2018 - Melorheostosis – Genetics Home Reference
May 25, 2018 - Non-addictive pain medication changing therapy for substance use disorders
May 25, 2018 - Delayed lactate measurements in sepsis patients increase risk of in-hospital death
May 25, 2018 - Researchers identify novel epigenetic mutations as cause of neurodevelopmental, congenital disorders
May 25, 2018 - UD researchers examine connection between DNA replication in HPV and cancer
May 25, 2018 - Researchers identify neurons that play key role in aggressive behavior
May 25, 2018 - Snail’s eye inspires new type of RIOCATH urinary catheter
May 25, 2018 - Russian researchers develop high-tech device-transformer for ultrasound examination
May 25, 2018 - Researchers discover unexpected chemosensor pathway for predator odor-evoked innate fear behaviors
May 25, 2018 - Researchers build 3-D printer that offers sweet solution to making detailed structures
May 25, 2018 - Nearly one in three people know someone addicted to opioids
May 25, 2018 - Research suggests link between faulty gene, alcohol, and heart failure
May 25, 2018 - New findings could help fine-tune treatment for cancer patients
May 25, 2018 - New cancer treatment approach targets specific sugar receptors
May 25, 2018 - Skin responsible for uptake of cancer-causing compounds during barbecuing than lungs
May 25, 2018 - Early-onset cannabis use linked to further drug abuse problems
May 25, 2018 - Covered California takes aim at hospital C-section rates
May 25, 2018 - FDA Approves Palynziq (pegvaliase-pqpz) for the Treatment of Adults with Phenylketonuria
May 25, 2018 - Arthritis Glossary
May 25, 2018 - Study links breast cancer to the body’s internal clock
May 25, 2018 - Strenuous exercise in teenage years may protect against height loss later in life
May 25, 2018 - FDA approves novel enzyme therapy for adults with rare and serious genetic disease
May 25, 2018 - New research project aims at developing effective interventions for kids with DLD

Researchers tackling deadly TB discuss the way forward in treatment and prevention

image_pdfDownload PDFimage_print

Researchers from across the world who are tacking the deadly bacterial disease tuberculosis (TB) attended a symposium at St George’s, University of London to discuss the way forward in treatment and prevention.

TB is one of the top 10 causes of death worldwide and in 2016, 10.4 million people fell ill with the disease and another 1.7 million died. Many of the deaths – 95% according to the World Health Organization – are among people have immune systems damaged by HIV.

The International Consortium for Trials of Chemotherapeutic Agents in Tuberculosis (INTERTB) group of experts meeting at St George’s was organized by Dr Amina Jindani, an Honorary Senior Lecturer.

So INTERTB is a consortium of all the groups in the world who carry out trials to improve treatment for drug-sensitive TB, and they have met annually at St George’s since 2009.

Dr Jindani was involved in some of the first TB drugs trials 50 years ago.

She explained: “When I started working in TB, the treatment was 18 months, and although the regimen was very effective, 18 months was just too long, and very few people completed the treatment.

“When two new drugs became available in the 1960s, rifampicin and pyrazinamide, from preclinical studies, it was thought that they would be able to shorten the treatment duration. The very first short course study that was ever done using these two drugs was done by the MRC, and I coordinated it in 42 centers in Kenya, Tanzania, Uganda and Zambia.”

Dr Jindani explained: “In spite of having a very effective six month treatment, the annual incidence is not decreasing; and the annual mortality remains at nearly 2 million in this is a curable disease. Why should 5000 people globally a day die of a curable disease? In any other situation it would be an outrage.”

“We have a safe, well-tolerated, highly effective treatment regimen but six months is still too long. After the first two months they feel well again, and so they stop taking their treatment.

“Then they relapse – if they relapse with drug-sensitive organisms that’s fine, but sometimes they relapse with drug-resistant organisms.  What we need is an effective vaccine, but in the absence of that, the only thing we can do to encourage compliance and completion of treatment, and increase the cure rates, is to reduce treatment duration.”

Rather than use new drugs, Dr Jindani’s main efforts are going into making one of the existing drugs – rifampicin – more effective by increasing its dose in the hope that treatment can come down to four months.

She is leading a new trial, RIFASHORT, to test using higher doses of rifampicin, and to have just four months of treatment.

She said: “In one arm we’re doubling the dose of rifampicin, in another we’re tripling the dose of rifampicin for four months”, she said, “because we have some pre-clinical evidence that that might kill off the persisting bacteria, and that’s the aim now, to eliminate the persistent bacteria”.

Another St George’s expert, Professor Julia Critchley is Professor of Epidemiology in the Population Health Research Institute, spoke to the delegates at the INTERTB meeting about her concerns regarding the concern that people with diabetes are three-times more likely to get TB than people without diabetes, possibly because their immune system is less effective in a way that the TB bacteria exploit.

Genetic factors and diet changes are considered the most probable causes of the rise in diabetes in Africa and Asia.

Dr Jindani said, “So Indians have a genetic disposition to developing diabetes. In the other countries, diets are changing. For example in the past I never saw a fat person in Africa, and now I do, because they’re all eating junk food. There again the levels of diabetes are going up exponentially, and they risk getting TB.”

Source:

https://sgul.ac.uk/news/news-archive/experts-tackling-deadly-tuberculosis-say-thousands-are-dying-of-the-curable-disease-each-day

Tagged with:

About author

Related Articles